Back
Deluxe Corp. 10K Form
Buy
79
DLX
Deluxe Corp.
Last Price:
$20.99
Seasonality Move:
3.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-03 | 10Q | DLX/Deluxe Corp. Quarterly |
| 2023-11-03 | 10Q | DLX/Deluxe Corp. Quarterly |
| 2023-08-04 | 10Q | DLX/Deluxe Corp. Quarterly |
| 2023-05-09 | 10Q | DLX/Deluxe Corp. Quarterly |
| 2022-11-04 | 10Q | DLX/Deluxe Corp. Quarterly |
| 2022-08-05 | 10Q | DLX/Deluxe Corp. Quarterly |
Receive DLX News And Ratings
See the #1 stock for the next 7 days that we like better than DLX
DLX Financial Statistics
Sales & Book Value
| Annual Sales: | $2.1B |
|---|---|
| Cash Flow: | $43.9M |
| Price / Cash Flow: | 7.19 |
| Annual Sales: | $14.76 |
| Price / Book: | 1.42 |
Profitability
| EPS (TTM): | 1.82450 |
|---|---|
| Net Income (TTM): | $82.8M |
| Gross Margin: | $1.1B |
| Return on Equity: | 13.11% |
| Return on Assets: | 3.15% |
Deluxe Corp. Earnings Forecast
Key Deluxe Corp. Financial Ratios
-
The Gross Profit Margin over the past 45 years for DLX is 53.18%.
-
The Selling, General & Administrative Expenses for DLX have been equal to 42.85% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 238.19% of Operating Income.
-
The Net Earning history of DLX is 2.49% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 19 years.
Deluxe Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Commercial Services & Supplies |
| Sector: | Industrials |
| Current Symbol: | DLX |
| CUSIP: | 248019 |
| Website: | deluxe.com |
Debt
| Debt-to-Equity Ratio: | 2.26 |
|---|---|
| Current Ratio: | 0.99 |
| Quick Ratio: | 0.65 |
Price-to-Earnings
| Trailing P/E Ratio: | 17.7 |
|---|---|
| Forward P/E Ratio: | 5.49 |
DLX Technical Analysis vs Fundamental Analysis
Buy
79
Deluxe Corp. (DLX)
is a Buy
Is Deluxe Corp. a Buy or a Sell?
-
Deluxe Corp. stock is rated a BuyThe current Deluxe Corp. [DLX] share price is $20.89. The Score for DLX is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.